SUBSCRIBE
SUBSCRIBE

Nevada

PRESS RELEASES
Press Releases
Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - May 4, 2026
May 5, 2026
 · 
1 min read
Press Releases
BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson’s Disease ahead of Topline Data in 2Q26, on May 7, 2026
April 27, 2026
 · 
5 min read
Press Releases
BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting
April 14, 2026
 · 
3 min read
Press Releases
Avaí Bio and Austrianova to Present Latest Data on Klotho Anti-Aging Therapy at Annual Klotho Conference
April 7, 2026
 · 
3 min read
Press Releases
Restore Robotics Receives FDA 510(k) Clearance for Two Additional da Vinci Xi® Robotic Instruments
April 1, 2026
 · 
2 min read
Press Releases
Takara Bio USA and Hamilton Company Partner to Automate NGS Library Preparation
March 30, 2026
 · 
3 min read
Press Releases
RMTG Subsidiary Cellgenic Commences Full-Scale Manufacturing at First-of-Its-Kind
March 26, 2026
 · 
8 min read
Press Releases
Zura Bio Reports Full Year 2025 Financial Results and Recent Corporate Updates
March 20, 2026
 · 
9 min read
Press Releases
BioVie Announces Abstract Accepted for Presentation at AD/PD 2026
March 12, 2026
 · 
3 min read
Press Releases
Auragens Officially Launches Dedicated Orthobiologics Division, A First in the Field by a Regenerative Medicine and Research Institute
March 10, 2026
 · 
3 min read
Press Releases
GE HealthCare to showcase AI and digital leadership at HIMSS 2026
March 5, 2026
 · 
7 min read
Press Releases
Zura Bio to Present Phase 2 TibuSURE Study Design Poster Evaluating Dual IL-17A and BAFF Inhibition in Systemic Sclerosis at 9th Systemic Sclerosis World Congress
March 5, 2026
 · 
6 min read
Press Releases
Esperion Therapeutics and Corstasis Therapeutics Announce Esperion’s Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)
March 3, 2026
 · 
11 min read
Press Releases
Zura Bio to Participate in Upcoming March 2026 Investor Conferences
March 2, 2026
 · 
1 min read
Press Releases
Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants
February 25, 2026
 · 
4 min read
Press Releases
Ultima Genomics and Hamilton Partner to Automate Sample Preparation and Amplification Workflows for the Ultima Family of Sequencing Systems to Enable Improved Lab Operations and Drive Sequencing at Scale
February 25, 2026
 · 
5 min read
Press Releases
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on March 4
February 23, 2026
 · 
3 min read
Press Releases
Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D., Ph.D., to Board of Directors
February 23, 2026
 · 
4 min read
Press Releases
BioVie Announces Abstracts Accepted for Presentation at the 2026 American College of Psychiatrists Annual Meeting
February 12, 2026
 · 
3 min read
Press Releases
Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit
February 5, 2026
 · 
1 min read
Load More